Click on a filter below to refine your search. Remove a filter to broaden your search.
The greatest increase in utilization was seen for veterans aged 85 years and older (6.1 visits) versus those aged 20 to 44 years (4.8 visits).
And patients aged ≥60 years hospitalized with RSV are more likely to have severe illness than those with COVID-19 or influenza.
An increase was seen during the pandemic period, following a decrease between 1950 and 2019; child mortality continued to drop during the pandemic.
Baricitinib plus remdesivir was linked to a reduced risk of death and progression to invasive mechanical ventilation.
The Office of Long COVID Research and Practice will lead the US response to long COVID, which includes trials that already have been launched.
The odds of invasive mechanical ventilation and death significantly increased for those with RSV versus vaccinated COVID and flu.
Those who survived COVID-19 had reduced mortality on days 181 to 365 and 366 to 730.
March 2020 to November 2022 saw a decline in crude in-hospital mortality for SARS-CoV-2-linked sepsis from 33.4 to 14.9%.
Physical, psychiatric and cognitive problems were seen in those discharged to long-term acute care hospitals.
A reduced risk was seen for venous thromboembolism, arterial thrombosis/thromboembolism and heart failure.